SS Innovations International (SSII) Income from Continuing Operations (2016 - 2026)
SS Innovations International recorded quarterly Income from Continuing Operations of 3582571.0 in Q1 2026, down 122.02% quarter-over-quarter from 16270105.0 in Q4 2025, and up 36.94% year-over-year from 2616130.76 in Q1 2025.
SS Innovations International's Income from Continuing Operations history runs 11 years deep, the most recent figure standing at 3582571.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations rose 36.94% year-over-year to 3582571.0; the TTM figure through Mar 2026 stood at 8712879.0 (up 129.13% YoY), while the FY2025 annual figure was 2606194.0, up 113.61% from the prior year.
- Income from Continuing Operations came in at 3582571.0 for Q1 2026 at SS Innovations International, down from 16270105.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 16270105.0 in Q4 2025 to a low of 16845069.0 in Q4 2024.
- A 5-year average of 2741068.59 and a median of 2173238.0 in 2024 frame the typical range for Income from Continuing Operations.
- Across the five-year window, Income from Continuing Operations slumped 1532.68% in 2023 and surged 196.59% in 2025, its largest moves.
- SS Innovations International's Income from Continuing Operations stood at 1028208.0 in 2022, then tumbled by 1080.91% to 12142250.0 in 2023, then sank by 38.73% to 16845069.0 in 2024, then surged by 196.59% to 16270105.0 in 2025, then plunged by 122.02% to 3582571.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 3582571.0, 16270105.0, and 3717964.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 220.30 Mn |
| 10 | SS Innovations International | 770.31 Mn | 746.70 Mn | 5.33 Mn | -3.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.58 Mn |
| Dec 31, 2025 | 16.27 Mn |
| Sep 30, 2025 | -3.72 Mn |
| Jun 30, 2025 | -256,691.00 |
| Mar 31, 2025 | -5.68 Mn |
| Dec 31, 2024 | -16.85 Mn |
| Sep 30, 2024 | -3.25 Mn |
| Jun 30, 2024 | -4.14 Mn |
| Mar 31, 2024 | -2.17 Mn |
| Dec 31, 2023 | -12.14 Mn |
| Sep 30, 2023 | -1.90 Mn |
| Jun 30, 2023 | -5.52 Mn |
| Mar 31, 2023 | -1.31 Mn |
| Dec 31, 2022 | -1.03 Mn |
| Sep 30, 2022 | -486,386.00 |
| Jun 30, 2022 | -752,025.00 |
| Mar 31, 2022 | -80,421.00 |
| Dec 31, 2021 | -352,956.00 |
| Sep 30, 2021 | -418,209.00 |
| Jun 30, 2021 | -412,314.00 |
| Mar 31, 2021 | -300,056.00 |
| Dec 31, 2020 | -221,840.00 |
| Sep 30, 2020 | -375,526.00 |
| Jun 30, 2020 | -220,301.00 |
| Mar 31, 2020 | -307,015.00 |
| Dec 31, 2019 | -1.05 Mn |
| Sep 30, 2019 | -1.40 Mn |
| Jun 30, 2019 | -539,000.00 |
| Mar 31, 2019 | -395,481.00 |
| Dec 31, 2018 | -219,137.00 |
| Sep 30, 2018 | -297,272.00 |
| Jun 30, 2018 | -205,509.00 |
| Mar 31, 2018 | -238,404.00 |
| Dec 31, 2017 | -473,964.00 |
| Sep 30, 2017 | -180,067.00 |
| Jun 30, 2017 | -187,376.00 |
| Mar 31, 2017 | -196,315.00 |
| Dec 31, 2016 | -194,840.00 |
| Sep 30, 2016 | -246,866.00 |
| Jun 30, 2016 | -43,242.00 |